Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1365837
Abstract: ABSTRACT Introduction: India accounts for 25% of the global burden of MDR-TB. In 2016, the India’s Revised National TB Control Programme reported a success rate of 46% among 19,298 MDR-TB patients treated under the programme.… read more here.
Keywords: developing therapies; mdr india; mdr; treatment ... See more keywords
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13090
Abstract: Forty percent of Hodgkin lymphoma (HL) patients are older than 50 years at diagnosis, a fact which is not commonly recognized. Older patients do significantly worse than younger patients and are rarely included in clinical… read more here.
Keywords: developing therapies; paid developing; hodgkin lymphoma; greater attention ... See more keywords
Developing Therapies for Neurodegenerative Disorders: Insights from Protein Aggregation and Cellular Stress Responses.
Sign Up to like & getrecommendations! Published in 2020 at "Annual review of cell and developmental biology"
DOI: 10.1146/annurev-cellbio-040320-120625
Abstract: As the world's population ages, neurodegenerative disorders are poised to become the commonest cause of death. Despite this, they remain essentially untreatable. Characterized pathologically both by the aggregation of disease-specific misfolded proteins and by changes… read more here.
Keywords: developing therapies; neurodegenerative disorders; disease; stress ... See more keywords